NASDAQ: CNTB
Connect Biopharma Holdings Ltd Stock Ownership - Who owns Connect Biopharma Holdings?

Insider buying vs selling

Have Connect Biopharma Holdings Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James HuangDirector2026-03-311,160,000$3.45
$4.00MBuy

1 of 1

CNTB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTB insiders and whales buy or sell their stock.

CNTB Shareholders

What type of owners hold Connect Biopharma Holdings Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Huang23.28%13,160,000$33.29MInsider
Ikarian Capital LLC8.47%4,788,486$12.11MInstitution
Boothbay Fund Management LLC2.18%1,234,582$3.12MInstitution
Perceptive Advisors LLC1.40%792,696$2.01MInstitution
Bml Capital Management LLC0.72%408,887$1.03MInstitution
Barry D. Quart0.40%224,034$566.81kInsider
David Leslie Szekeres0.38%215,739$545.82kInsider
Knott David M Jr0.35%200,000$506.00kInstitution
Richmond Brothers Inc0.31%173,485$438.92kInstitution
Renaissance Technologies LLC0.25%143,100$362.04kInstitution

1 of 3

CNTB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTB14.98%24.31%Net BuyingNet Buying
HURA10.15%29.71%
TLSA2.64%40.06%
IPHA0.29%0.00%
SPRO36.48%62.44%Net SellingNet Selling

Connect Biopharma Holdings Stock Ownership FAQ

Who owns Connect Biopharma Holdings?

Connect Biopharma Holdings (NASDAQ: CNTB) is owned by 14.98% institutional shareholders, 24.31% Connect Biopharma Holdings insiders, and 60.71% retail investors. James Huang is the largest individual Connect Biopharma Holdings shareholder, owning 13.16M shares representing 23.28% of the company. James Huang's Connect Biopharma Holdings shares are currently valued at $32.51M.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.